9 assets in Movement Disorder

Therapeutic assets addressing Movement Disorder, rated under Floatz methodology v0.2 and sorted by current rating.

Asset	Sponsor	Phase	Rating
Lemborexant Movement Disorder	YangPan	P4	BB (65)
Live Combined Bifidobacterium Movement Disorder	Beijing Friendship Hospital	P4	BB (65)
Live Combined Bifidobacterium,Lactobacillus And Enterococcus Capsules Movement Disorder	Beijing Friendship Hospital	P4	BB (65)
Maltodextrin Movement Disorder	RDC Clinical Pty Ltd	P3	BB (64)
Maolactin Movement Disorder	RDC Clinical Pty Ltd	P3	BB (64)
(±)-2-(O-Chlorophenyl)-2-(Methylamino)Cyclohexanone Movement Disorder	PharmaTher Inc.	P2	CCC (53)
8-AZABICYCLO(3.2.1)OCTANE-2-CARBOXYLIC ACID, 3-(4-FLUOROPHENYL)-8-((2E)-3-IODO-2-PROPEN-1-YL)-, METHYL ESTER, (1R,2S,3S,5S)- Movement Disorder	GE Healthcare	P2	CCC (53)
Midazolam Movement Disorder	PharmaTher Inc.	P2	CCC (53)
Alloex Exosomes Movement Disorder	The Foundation for Orthopaedics and Regenerative Medicine	P1	NR ()